Clinical management of HCV carriers with normal aminotransferase levels
- 1 May 2003
- journal article
- guideline
- Published by Elsevier in Digestive and Liver Disease
- Vol. 35 (5) , 362-369
- https://doi.org/10.1016/s1590-8658(03)00185-3
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase LevelsAnnals of Internal Medicine, 2002
- Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)Journal of Hepatology, 2002
- Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNAHepatology, 2001
- Natural history of hepatitis C virus carriers with persistently normal aminotransferase levelsGastroenterology, 2000
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis CHepatology, 1998
- Asymptomatic anti-HCV seropositive subjects include patients with chronic active hepatitis and individuals with normal liver: can we distinguish them?Journal of Hepatology, 1994
- Normal aminotransferase concentrations in patients with antibodies to hepatitis C virusBMJ, 1994
- Detection of plus and minus HCV RNA in normal liver of anti-HCV-positive patientsThe Lancet, 1993
- Persistent hepatitis C viraemia without liver diseaseThe Lancet, 1993